Application no. and date | 13713199.1 (espacenet) (Federated) (European Patent Register), 20130402 | Patent/reg. no. and date | DK/EP 2833884, 20200520 | Publication date | 20150211 | Priority no. and date | EP 12162937, 20120403 | EP pub. no. and date |
EP 2833884 20150211 | Effective date | | Applicant/owner | Alkahest, Inc., 125 Shoreway Road, Suite D
San Carlos, CA 94070, US | Applicant ref. no. | P024369EPDK1 | Inventor | NIVENS, Michael Chadham, Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein, DE, BOUYSSOU, Thierry, Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein, DE, GOEGGEL, Rolf, Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein, DE, SEITHER, Peter, Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim Am Rhein, DE | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/4545 (2006.01) , A61P 11/00 (2006.01) , A61P 27/02 (2006.01) , A61P 37/00 (2006.01) | Title | ANVENDELSE AF CCR3-INHIBITORER | Int. application no. | EP2013056864 | Int. publication no. | WO2013149986 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|